Sales & Marketing ADHD medication scarcity adds to questions on US supply chai... Ben Hargreaves looks into why ADHD medicines are still suffering shortages nearly a year after first being announced.
News FDA knocks back AstraZeneca's self-injected lupus drug FDA has delivered a setback to AstraZeneca by rebuffing its new formulation of lupus therapy Saphnelo, which was approved in Europe last year.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.